Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 810-813, 2003; 10.1373/49.5.810
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsen, Y.-C.
Right arrow Articles by Chiou, Y-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsen, Y.-C.
Right arrow Articles by Chiou, Y-N.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2003;49:810-813.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Evaluation and Validation of a Duck IgY Antibody-based Immunoassay for High-Sensitivity C-reactive Protein: Avian Antibody Application in Clinical Diagnostics

Yun-Chien Tsen1, Guor-Yuan Kao1, Chung-Li Chang1, Fang-Yu Lai1, Chien-Hsun Huang1, San Ouyang1, Mei-Huei Yu2, Chi-Pin Wang3 and Y-Neng Chiou1,a

1 Good Biotech Corp., No. 38 34th Road, Taichung Industrial Park, Taichung 407, Taiwan;

2 Kuang Tien General Hospital Laboratory, Taichung 433, Taiwan;

3 Chung Shan Medical University Hospital, Taichung 402, Taiwan;

aauthor for correspondence: fax 886-4-23590410, e-mail gbc@good-biotech.com

The first 20% of the full text of this article appears below.

High-sensitivity C-reactive protein (hs-CRP) is considered one of the most promising markers for cardiac risk assessment (1). A highly sensitive and interference-resistant CRP assay plays an important role in accurate CRP measurements (2)(3); therefore, manufacturers of in vitro diagnostics have begun modifying their existing CRP assays to meet the requirements. Mammalian antibodies, e.g., rabbit, mouse, and goat IgGs, are the major ones used in clinical immunoassays, but they have some drawbacks. Within the past 10 years, it has been reported that rheumatoid factor and heterophilic antibodies present in samples have caused false-positive results in CRP measurements (4)(5)(6). In addition, monoclonal antibodies for use as diagnostic and therapeutic reagents can induce human anti-mouse antibodies, which may interfere with mammalian IgGs in immunoassays, especially in the sandwich-type methods (7).

To eliminate interference without increasing costs, avian antibodies are now considered potential candidates to improve current immunoassays. One such assay, the CRPex-HS® C-Reactive Protein LIT assay (Good Biotech Corp., Taiwan), based on latex microparticle-enhanced immunoturbidimetry, has been developed and is commercially available. The CRPex-HS CRP LIT assay is intended to measure serum hs-CRP concentrations with use of a duck antibody. The duck anti-CRP IgY ({Delta}Fc) antibody is a good substitute for traditional mammalian antibodies. The antibody, purified from egg yolks of white Pekin ducks (Anas platyrhynchos), is coupled to polystyrene microparticles. When CRP in the serum sample encounters microparticles containing the duck anti-CRP IgY ({Delta}Fc), it agglutinates and the turbidity is measured at 570 nm. The assay calibration range is 0–20.0 mg/L. Practical CRP measurements by the CRPex-HS CRP LIT assay are conducted on a common automated chemistry analyzer, . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Appl. Environ. Microbiol.Home page
W. J. J. Finlay, I. Shaw, J. P. Reilly, and M. Kane
Generation of High-Affinity Chicken Single-Chain Fv Antibody Fragments for Measurement of the Pseudonitzschia pungens Toxin Domoic Acid.
Appl. Envir. Microbiol., May 1, 2006; 72(5): 3343 - 3349.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. Hakonarson, S. Thorvaldsson, A. Helgadottir, D. Gudbjartsson, F. Zink, M. Andresdottir, A. Manolescu, D. O. Arnar, K. Andersen, A. Sigurdsson, et al.
Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction: A Randomized Trial
JAMA, May 11, 2005; 293(18): 2245 - 2256.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.